NASD | Health Care | Biotechnology

Cue Biopharma, Inc. (CUE)

LAST (3 Apr)
0.7606
-0.0295  (-3.73%)
After-Hours (16:08:58 ET)
0.7500
-0.01  (-1.39%)
MARKET CAP
46.397 M
VOLUME
213,110
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 3 Apr
Open 0.76
Previous Close 0.7901
Day Range 0.70 - 0.80
52-Week Range 0.45 - 2.26
All-Time High 31.69
Avg. Volume (50-day) 185,618.73
EPS (TTM) -0.7493
Next Earnings Date 2025-05-15 (AMC)
Last Earnings Date 2025-03-31
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -1.0500
PEG Ratio -
Price to Book 2.79
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) 9.29 M
Revenue per Share (TTM) 0.13
Shares Outstanding 61.819 M
Share Float (%) 61.35 M (99.25%)
% Held by Institutions 20.65
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 0.96 (-20.77%)
+/- SMA(50) 1.18 (-35.54%)
+/- SMA(200) 1.08 (-29.57%)
5-Day Perf. -23.94%
1-Month Perf. -36.62%
3-Month Perf. -45.28%
6-Month Perf. -7.15%
YTD Perf. -30.22%
1-Year Perf. -57.03%
RSI(14) 27.37
ATR(14) 0.1
ADX(14) 28.32
Beta (5Y) 1.35
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

CUE

34.6
(+3.6)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Cue Biopharma, Inc.

40 Guest Street
Boston, Massachusetts
http://www.cuebiopharma.com
Sector: Health Care
Industry: Biotechnology
Employees: 41
Description

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Predefined Scans with CUE View All  

CUE has triggered the following predefined scans:

P&F Double Bottom Breakdown
Alerts for CUE View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with CUE

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.